glp-1 in type 1 diabetes Medications – Community Education GLP-1 receptor agonists | How

Our study provided valuable evidence for early clinical interventions and the identification of the risk of gastrointestinal toxicities

Then in July 2024, the monographs for Mounjaro and Trulicity were also updated with new warnings

Regular Check-Ins: Regular check-ins with your healthcare provider and coach help monitor your progress and make any necessary adjustments to your treatment plan

With a growing demand for GLP-1 agonists, pharmacists can help guide healthcare providers and patients about proper use, potential side effects, and what to expect

Epidemiological research suggests that control of these overlapping risk factors may present opportunities to prevent the development of these highly prevalent neuropathologies in high-risk populations, while also simultaneously improving cardiovascular health